Hjem › Akut lymfoblastisk leukemi
Kliniske studier for Akut lymfoblastisk leukemi rekrutterer i USA
134 studier for Akut lymfoblastisk leukemi rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Houston, TX28 studier
- New York City, NY24 studier
- Baldwin Park, CA21 studier
- Seattle, WA21 studier
- Chicago, IL19 studier
- Atlanta, GA19 studier
- Philadelphia, PA16 studier
- Memphis, TN16 studier
- Washington, DC16 studier
- Boston, MA15 studier
- Los Angeles, CA14 studier
- Durham, NC13 studier
- Mountain View, CA13 studier
- Cincinnati, OH12 studier
- Minneapolis, MN12 studier
- Columbus, OH11 studier
- Tampa, FL10 studier
- Salt Lake City, UT10 studier
- Portland, OR9 studier
- Baltimore, MD9 studier
- Miami, FL8 studier
- Aurora, CO8 studier
- Nashville, TN8 studier
- San Antonio, TX8 studier
- Charlotte, NC8 studier
- Edison, NJ8 studier
- Cleveland, OH7 studier
- Birmingham, AL7 studier
- Denver, CO7 studier
- Pittsburgh, PA6 studier
- Oklahoma City, OK6 studier
- Milwaukee, WI6 studier
- Detroit, MI6 studier
- Phoenix, AZ6 studier
- San Diego, CA6 studier
- St. Louis, MO6 studier
- Queens, NY6 studier
- San Francisco, CA5 studier
- Clifton, NJ5 studier
- The Bronx, NY5 studier
Etter delstat
- Alabama7 studier
- Arizona6 studier
- Arkansas5 studier
- California40 studier
- Colorado12 studier
- Connecticut3 studier
- District of Columbia10 studier
- Florida19 studier
- Georgia20 studier
- Hawaii3 studier
- Illinois20 studier
- Indiana6 studier
- Iowa5 studier
- Kansas5 studier
- Kentucky4 studier
- Louisiana6 studier
- Maine3 studier
- Maryland16 studier
- Massachusetts15 studier
- Michigan8 studier
- Minnesota14 studier
- Mississippi3 studier
- Missouri6 studier
- Nebraska4 studier
- Nevada3 studier
- New Jersey11 studier
- New Mexico3 studier
- New York32 studier
- North Carolina21 studier
- Ohio21 studier
- Oklahoma8 studier
- Oregon10 studier
- Pennsylvania21 studier
- Rhode Island3 studier
- South Carolina5 studier
- South Dakota3 studier
- Tennessee22 studier
- Texas30 studier
- Utah10 studier
- Virginia9 studier
- Washington22 studier
- West Virginia4 studier
- Wisconsin9 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
RekruttererFase 1
Opp til 75 år · Alle kjønn · Oppdatert 2. okt. 2026 · NCT01853631A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Rekrutterer
Alder 1 til 25 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05621291Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RekruttererFase 1
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06904066Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 1
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07572136Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservasjonsstudie
Alder 0 til 38 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06131801CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
RekruttererFase 2
Alder 3 til 65 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07328503CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
RekruttererFase 1/2
Alder 3 til 39 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT05442515A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RekruttererFase 1
Alder 12 til 78 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RekruttererFase 2
6 Months · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06514794Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06144606Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06398457Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
RekruttererObservasjonsstudie
4 Weeks – 18 Years · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06529575Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06308588Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06819475A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RekruttererFase 1/2
30 Days · Alle kjønn · Oppdatert 16. sep. 2026 · NCT04065399A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
RekruttererFase 1
Alder 0 til 18 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT06173518Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06904482Cord Blood Transplant in Adults With Blood Cancers
RekruttererFase 2
Alder 21 til 65 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT05884333Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
RekruttererFase 1/2
Alder 16 til 75 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT03104491Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
RekruttererFase 1
Alder 1 til 25 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06408194First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07586618Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
Opp til 50 år · Alle kjønn · Oppdatert 1. sep. 2026 · NCT05322850Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
RekruttererFase 1
Opp til 21 år · Alle kjønn · Oppdatert 31. aug. 2026 · NCT04881240CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
RekruttererFase 1
Opp til 21 år · Alle kjønn · Oppdatert 28. aug. 2026 · NCT07257419Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.